These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17058712)

  • 21. An autologous therapeutic dendritic cell vaccine transfected with total lung carcinoma RNA stimulates cytotoxic T lymphocyte responses against non-small cell lung cancer.
    Wang K; Zhou Q; Guo AL; Xu CR; An SJ; Wu YL
    Immunol Invest; 2009; 38(7):665-80. PubMed ID: 19811429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dendritic cells pulsed with gp96-peptide complexes derived from human hepatocellular carcinoma (HCC) induce specific cytotoxic T lymphocytes.
    Wang XH; Qin Y; Hu MH; Xie Y
    Cancer Immunol Immunother; 2005 Oct; 54(10):971-80. PubMed ID: 15965645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [An in vitro study of specific antitumor immunity induced by dendritic cells pulsed with tumor cell lysates from patients with hepatocellular carcinoma].
    Gao J; Chen M; Peng ML; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):198-201. PubMed ID: 15760555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative analysis of DC fused with tumor cells or transfected with tumor total RNA as potential cancer vaccines against hepatocellular carcinoma.
    Zhang HM; Zhang LW; Liu WC; Cheng J; Si XM; Ren J
    Cytotherapy; 2006; 8(6):580-8. PubMed ID: 17148035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative analysis of cytotoxic T lymphocyte response induced by dendritic cells loaded with hepatocellular carcinoma -derived RNA or cell lysate.
    Pan K; Zhao JJ; Wang H; Li JJ; Liang XT; Sun JC; Chen YB; Ma HQ; Liu Q; Xia JC
    Int J Biol Sci; 2010 Oct; 6(7):639-48. PubMed ID: 20975822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation of native and amplified tumour RNA for dendritic cell transfection and generation of in vitro anti-tumour CTL responses.
    Bergant M; Meden L; Repnik U; Sojar V; Stanisavljević D; Jeras M
    Immunobiology; 2006; 211(3):179-89. PubMed ID: 16530085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immune response of HBsAg gene-modified dendritic cell-based vaccine in HepG2. 2. 15 hepatocellular carcinoma cells].
    Yang JY; Liu WC; Cao DY; Si XM; Teng ZH
    Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):728-32. PubMed ID: 18396682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential therapeutic value of dendritic cells loaded with NY‑ESO‑1 protein for the immunotherapy of advanced hepatocellular carcinoma.
    Chen Y; Huang A; Gao M; Yan Y; Zhang W
    Int J Mol Med; 2013 Dec; 32(6):1366-72. PubMed ID: 24085111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative analysis of DC fused with allogeneic hepatocellular carcinoma cell line HepG2 and autologous tumor cells as potential cancer vaccines against hepatocellular carcinoma.
    Cao DY; Yang JY; Yue SQ; Tao KS; Song ZS; Wang DS; Yang YL; Dou KF
    Cell Immunol; 2009; 259(1):13-20. PubMed ID: 19545862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dendritic cells pulsed with Hsp70 and HBxAg induce specific antitumor immune responses in hepatitis B virus-associated hepatocellular carcinoma.
    Wang H; Feng F; Wang XP; Wang RS; Wu Y; Zhu MG; Zhang H; Zhuang ZX
    Mol Med Rep; 2016 Feb; 13(2):1077-82. PubMed ID: 26647961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma.
    Mizukoshi E; Nakamoto Y; Arai K; Yamashita T; Sakai A; Sakai Y; Kagaya T; Yamashita T; Honda M; Kaneko S
    Hepatology; 2011 Apr; 53(4):1206-16. PubMed ID: 21480325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor antigen pulsed dendritic cells enhance the cytolytic activity of tumor infiltrating lymphocytes in human hepatocellular cancer.
    Friedl J; Stift A; Paolini P; Roth E; Steger GG; Mader R; Jakesz R; Gnant MF
    Cancer Biother Radiopharm; 2000 Oct; 15(5):477-86. PubMed ID: 11155819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human dendritic cells transfected with renal tumor RNA stimulate polyclonal T-cell responses against antigens expressed by primary and metastatic tumors.
    Heiser A; Maurice MA; Yancey DR; Coleman DM; Dahm P; Vieweg J
    Cancer Res; 2001 Apr; 61(8):3388-93. PubMed ID: 11309297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of cytotoxic T lymphocytes primed with tumor RNA-loaded dendritic cells in esophageal squamous cell carcinoma: preliminary step for DC vaccine design.
    Gholamin M; Moaven O; Farshchian M; Mahmoudi M; Sankian M; Memar B; Forghani MN; Malekzadeh R; Rajabi-Mashhadi MT; Abbaszadegan MR
    BMC Cancer; 2010 Jun; 10():261. PubMed ID: 20525404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Killing effect of dendritic cell vaccine transfected by recombinant adeno-associated virus with hAFP gene fragment on hepatocellular carcinoma cells in vitro].
    Sun JH; Ma YL; Peng ME; Bie AG; Li L; Liu L
    Zhonghua Zhong Liu Za Zhi; 2010 May; 32(5):334-8. PubMed ID: 20723429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunotherapy based on dendritic cells pulsed with CTPFoxM1 fusion protein protects against the development of hepatocellular carcinoma.
    Su H; Li B; Zheng L; Wang H; Zhang L
    Oncotarget; 2016 Jul; 7(30):48401-48411. PubMed ID: 27351282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigen-specific T cell response from dendritic cell vaccination using side population cell-associated antigens targets hepatocellular carcinoma.
    Li X; Zhang Z; Lin G; Gao Y; Yan Z; Yin H; Sun B; Wang F; Zhang H; Chen H; Cao D
    Tumour Biol; 2016 Aug; 37(8):11267-78. PubMed ID: 26951511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunomodulatory dendritic cells generated from nonfractionated bulk peripheral blood mononuclear cell cultures induce growth of cytotoxic T cells against renal cell carcinoma.
    Hinkel A; Tso CL; Gitlitz BJ; Neagos N; Schmid I; Paik SH; deKernion J; Figlin R; Belldegrun A
    J Immunother; 2000 Jan; 23(1):83-93. PubMed ID: 10687141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of cytotoxic T lymphocytes on hepatoma cell line SMMC-7721 induced by different subsets of dendritic cells in vitro.
    Wang JX; Liu GH; Fan YZ; Liu QL; Zhou J; Zhang DY; Qi YM
    Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):422-7. PubMed ID: 16911943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of cytotoxic T lymphocytes from the peripheral blood of a hepatocellular carcinoma patient using melanoma antigen-1 (MAGE-1) peptide.
    Lu J; Leng X; Peng J; Mou D; Pang X; Shang X; Chen W
    Chin Med J (Engl); 2002 Jul; 115(7):1002-5. PubMed ID: 12150730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.